$BOLD Audentes Therapeutics, Inc. Insider Trading Week 30/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Audentes Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Audentes Therapeutics, Inc. in week 30/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 1,249 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 3,029 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 6,811 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,410 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 480,856 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 1,081,477 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | P | 15.00 | 219 | 3,285 | 11,308 | 11.1 K to 11.3 K (+1.97 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | P | 15.00 | 34,781 | 521,715 | 1,795,524 | 1.8 M to 1.8 M (+1.98 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 1,249 | 0 | 11,089 | 9.8 K to 11.1 K (+12.69 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 3,029 | 0 | 9,840 | 6.8 K to 9.8 K (+44.47 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 6,811 | 0 | 6,811 | 0 to 6.8 K |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,410 | 0 | 1,760,743 | 1.6 M to 1.8 M (+12.70 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 480,856 | 0 | 1,562,333 | 1.1 M to 1.6 M (+44.46 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 1,081,477 | 0 | 1,081,477 | 0 to 1.1 M |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,249 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,029 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,811 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 198,410 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 480,856 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,081,477 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | P | 15.00 | 219 | 3,285 | 11,308 | 11.1 K to 11.3 K (+1.97 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | P | 15.00 | 34,781 | 521,715 | 1,795,524 | 1.8 M to 1.8 M (+1.98 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 1,249 | 0 | 11,089 | 9.8 K to 11.1 K (+12.69 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 3,029 | 0 | 9,840 | 6.8 K to 9.8 K (+44.47 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 6,811 | 0 | 6,811 | 0 to 6.8 K |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 198,410 | 0 | 1,760,743 | 1.6 M to 1.8 M (+12.70 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 480,856 | 0 | 1,562,333 | 1.1 M to 1.6 M (+44.46 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 1,081,477 | 0 | 1,081,477 | 0 to 1.1 M |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,511,441 | 0 | 3,363,546 | 852.1 K to 3.4 M (+294.73 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 627,867 | 0 | 852,105 | 224.2 K to 852.1 K (+280.00 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,511,441 | 0 | 3,363,546 | 852.1 K to 3.4 M (+294.73 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 627,867 | 0 | 852,105 | 224.2 K to 852.1 K (+280.00 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | C | 0.00 | 2,233 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | C | 0.00 | 13,400 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | C | 0.00 | 9,000 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Buy | C | 0.00 | 2,233 | 0 | 14,555 | 12.3 K to 14.6 K (+18.12 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Buy | C | 0.00 | 13,400 | 0 | 87,343 | 73.9 K to 87.3 K (+18.12 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Buy | C | 0.00 | 9,000 | 0 | 475,799 | 466.8 K to 475.8 K (+1.93 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,688 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 15,898 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 35,755 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 259,524 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 616,874 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,387,392 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | P | 15.00 | 1,759 | 26,385 | 60,100 | 58.3 K to 60.1 K (+3.02 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | P | 15.00 | 68,241 | 1,023,615 | 2,332,031 | 2.3 M to 2.3 M (+3.01 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 6,688 | 0 | 58,341 | 51.7 K to 58.3 K (+12.95 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 15,898 | 0 | 51,653 | 35.8 K to 51.7 K (+44.46 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 35,755 | 0 | 35,755 | 0 to 35.8 K |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 259,524 | 0 | 2,263,790 | 2 M to 2.3 M (+12.95 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 616,874 | 0 | 2,004,266 | 1.4 M to 2 M (+44.46 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | 10% Owner | Buy | C | 0.00 | 1,387,392 | 0 | 1,387,392 | 0 to 1.4 M |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 99,830 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 99,830 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 267,998 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 535,996 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 146,596 | 2,198,940 | 514,424 | 367.8 K to 514.4 K (+39.85 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 253,404 | 3,801,060 | 889,230 | 635.8 K to 889.2 K (+39.85 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 99,830 | 0 | 367,828 | 268 K to 367.8 K (+37.25 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 99,830 | 0 | 635,826 | 536 K to 635.8 K (+18.63 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 267,998 | 0 | 267,998 | 0 to 268 K |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 535,996 | 0 | 535,996 | 0 to 536 K |